Trade AbbVie ^ABBV

AbbVie (NYSE:ABBV) Shares Up 2% - Time to Buy?

Here’s Why Brown Capital Management Small Company Fund Sold Ironwood Pharmaceuticals (IRWD)

Alembic Pharmaceuticals receives USFDA approval for Divalproex Sodium | Capital Market News - Business Standard

Comparing BriaCell Therapeutics (OTCMKTS:BCTXF) & AbbVie (NYSE:ABBV)

USFDA gives nod to Alembic Pharma’s anti-epileptic drug

Pharma Stock Roundup: PFE's 2025 Outlook, MRK & ABBV's M&A Deals - December 20, 2024 - Zacks.com

AbbVie (NYSE:ABBV) Stock Price Down 0.5% on Insider Selling

AbbVie Says Canadian Headache Society Backs Atogepant, OnabotulinumtoxinA | Markets Insider

Is AbbVie Inc. (ABBV) the Safest Dividend Stock to Invest In Now?

Kevin K. Buckbee Sells 1,800 Shares of AbbVie Inc. (NYSE:ABBV) Stock

Novartis, AbbVie Score Win to Block West Virginia Drug Limit Law

AbbVie's SWOT analysis: biopharma giant navigates post-Humira landscape By Investing.com

Abbvie SVP Kevin Buckbee sells stock for $310,032 By Investing.com

AbbVie Inc. (NYSE:ABBV) Receives Average Recommendation of "Moderate Buy" from Brokerages

Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know - December 18, 2024 - Zacks.com

Strength Seen in Sanofi (SNY): Can Its 6.7% Jump Turn into More Strength? - December 18, 2024 - Zacks.com

AbbVie's (ABBV) Overweight Rating Reiterated at Piper Sandler Companies

AbbVie (NYSE:ABBV) Price Target Raised to $220.00 at Piper Sandler

AbbVie shares price target lifted, rating held on strong drug outlook By Investing.com

4 Big Drug Stocks That May Continue to Outperform in 2025 - December 17, 2024 - Zacks.com

AbbVie, Novartis Drop Suit Over Kansas Drug Discount Limit Law

AbbVie (ABBV) Stock Declines While Market Improves: Some Information for Investors - December 16, 2024 - Zacks.com

ABBV to Acquire Nimble Therapeutics to Strengthen Immunology Pipeline - December 16, 2024 - Zacks.com

ABBV's Acquisition Spree Continues: Buy, Sell or Hold the Stock? - December 16, 2024 - Zacks.com

AbbVie (NYSE:ABBV) Shares Up 0.1% – Here’s What Happened

AbbVie (NYSE:ABBV) Stock Price Down 0.1% – Here’s What Happened

Lord Abbett & CO. LLC Decreases Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by B. Riley Wealth Advisors Inc.

AbbVie (ABBV) Announces Leadership Transition in Financial Department

Turns Out That Biosimilars Do Impact Biologic Drug Costs | MedPage Today

Asset Advisors Investment Management LLC Has $19.22 Million Position in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Stock Price Up 0.1% - Still a Buy?

AbbVie Inc. (NYSE:ABBV) Stake Lifted by Old North State Trust LLC

Synovus Financial Corp Sells 1,295 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie To Acquire Nimble Therapeutics For $200 Mln In Cash

AbbVie to Acquire Nimble Therapeutics, Further Strengthening

AbbVie Buying Nimble Therapeutics for $200 Million to Boost Immunology Pipeline | Morningstar

Retirement Systems of Alabama Sells 54,280 Shares of AbbVie Inc. (NYSE:ABBV)

24,146 Shares in AbbVie Inc. (NYSE:ABBV) Bought by Oddo BHF Asset Management Sas

AbbVie Inc. (NYSE:ABBV) Shares Sold by Franklin Resources Inc.

AbbVie set to acquire Nimble Therapeutics for $200 million By Investing.com

Stock Yards Bank & Trust Co. Has $14.81 Million Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Anchor Investment Management LLC

AbbVie (NYSE:ABBV) Shares Down 0.1% - Should You Sell?

Wilmington Savings Fund Society FSB Boosts Stock Position in AbbVie Inc. (NYSE:ABBV)

Arvest Bank Trust Division Takes Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by World Investment Advisors LLC

Sanctuary Advisors LLC Has $104.43 Million Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Pine Valley Investments Ltd Liability Co

Wealthquest Corp Has $545,000 Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Why AbbVie Inc. (ABBV) Is the Best Safe Stock to Buy According to Analysts?

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Hohimer Wealth Management LLC

AbbVie's SWOT analysis: stock resilience amid humira decline fuels growth By Investing.com

RA Capital Management Announces Close of $1.4 Billion Acquisition of Aliada Therapeutics by AbbVie | Morningstar

AbbVie (NYSE:ABBV) Shares Down 0.1% - Here's What Happened

Wall Street analysts love these dividend aristocrats heading into new year

Rehmann Capital Advisory Group Sells 380 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by McIlrath & Eck LLC

Soltis Investment Advisors LLC Sells 765 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Stock Position Trimmed by McIlrath & Eck LLC

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Executive Wealth Management LLC

Invst LLC Has $770,000 Stock Holdings in AbbVie Inc. (NYSE:ABBV)

HEALTHCARE: AbbVie (ABBV: A3 pos / A-): Aliada Acquisition

Medical Aesthetics Market worth $35.32 billion by 2030

Arete Wealth Advisors LLC Makes New Investment in AbbVie Inc. (NYSE:ABBV)

Toronto Dominion Bank Reduces Stake in AbbVie Inc. (NYSE:ABBV)

Chiron Investment Management LLC Buys Shares of 10,752 AbbVie Inc. (NYSE:ABBV)

Groupama Asset Managment Purchases 38,974 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie acquires Aliada to enhance Alzheimer's treatment By Investing.com

AbbVie Completes Acquisition Of Aliada

Hope for Parkinson’s disease symptoms is found in late-stage drug study

AbbVie (NYSE:ABBV) Trading Down 1.4% - Here's What Happened

AbbVie Inc. (NYSE:ABBV) Shares Sold by Geode Capital Management LLC

AbbVie Inc. (NYSE:ABBV) Stock Holdings Lifted by Ashford Capital Management Inc.

Medincell Publishes Its Consolidated Half-year Financial Results | Morningstar

AbbVie (NYSE:ABBV) Given “Neutral” Rating at Bank of America

Greenwood Gearhart Inc. Buys New Holdings in AbbVie Inc. (NYSE:ABBV)

TD Cowen names AbbVie a top pick for 2025 with buy stock rating By Investing.com

AbbVie's (ABBV) Neutral Rating Reiterated at Bank of America

Geode Capital Management LLC Lowers Stake in AbbVie Inc. (NYSE:ABBV)

Goodman Advisory Group LLC Purchases 1,620 Shares of AbbVie Inc. (NYSE:ABBV)

The Zacks Analyst Blog Highlights Eli Lilly, AbbVie, Gilead Sciences, Air T and Fossil Group

AbbVie (NYSE:ABBV) Trading 0.8% Higher - Here's Why

Study: Parkinson's Disease Drug Improves Symptoms | Newsmax.com

HEALTHCARE: AbbVie (ABBV: A3 pos / A-): Parkinson's Success

PYA Waltman Capital LLC Grows Stock Position in AbbVie Inc. (NYSE:ABBV)

Correction to AbbVie Tavapadon Phase 3 Study Article | Morningstar

AbbVie Says Phase 3 TEMPO-2 Study Of Tavapadon In Early Parkinson's Disease Met Main Goal | Markets Insider

Hamilton Capital LLC Boosts Stock Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie's Tavapadon Hits Key Goals in Third Phase 3 Parkinson's Study | Morningstar

AbbVie's Tavapadon Hits Key Goals in Second Phase 3 Parkinson's Study | Morningstar

AbbVie Announces Positive Topline Results for the Phase 3 TEMPO-2 Trial Evaluating Tavapadon as a Monotherapy for Parkinson's Disease | Morningstar

Analyst revises Amazon stock forecast following major 'moonshot' initiative

Stock market today: 3 bullish stocks that J.P. Morgan Just Upgraded

Bitcoin news today: Jerome Powell Says Fed Won’t Hold Bitcoin

Gold performance and prediction: how high could gold price go?

Week ahead: Last full week of 2024 in the Financial Markets

Stock market today: Nasdaq Hits Record Highs as Tesla Achieves New Peaks

Dow Jones tumbles 1,100 points: why did the stock market go down today?

Super Micro Shares Drop 8% Following Nasdaq 100 Removal